Detalhe da pesquisa
1.
Spatial and quantitative mapping of glycolysis and hypoxia in glioblastoma as a predictor of radiotherapy response and sites of relapse.
Eur J Nucl Med Mol Imaging
; 47(6): 1476-1485, 2020 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-32025750
2.
The role of early magnetic resonance imaging in predicting survival on bevacizumab for recurrent glioblastoma: Results from a prospective clinical trial (CABARET).
Cancer
; 123(18): 3576-3582, 2017 Sep 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-28678383
3.
Inefficiencies in phase II to phase III transition impeding successful drug development in glioblastoma.
Neurooncol Adv
; 3(1): vdaa171, 2021.
Artigo
em Inglês
| MEDLINE | ID: mdl-33543145
4.
LUMOS - Low and Intermediate Grade Glioma Umbrella Study of Molecular Guided TherapieS at relapse: Protocol for a pilot study.
BMJ Open
; 11(12): e054075, 2021 12 30.
Artigo
em Inglês
| MEDLINE | ID: mdl-37185327
5.
Biomarkers and smart intracranial devices for the diagnosis, treatment, and monitoring of high-grade gliomas: a review of the literature and future prospects.
Neurooncol Adv
; 1(1): vdz013, 2019.
Artigo
em Inglês
| MEDLINE | ID: mdl-32642651
6.
Correlation of hypoxic cell fraction and angiogenesis with glucose metabolic rate in gliomas using 18F-fluoromisonidazole, 18F-FDG PET, and immunohistochemical studies.
J Nucl Med
; 47(3): 410-8, 2006 Mar.
Artigo
em Inglês
| MEDLINE | ID: mdl-16513609
7.
Phase 2 study of temozolomide and Caelyx in patients with recurrent glioblastoma multiforme.
Neuro Oncol
; 6(1): 38-43, 2004 Jan.
Artigo
em Inglês
| MEDLINE | ID: mdl-14769139
8.
Phase III study of enzastaurin compared with lomustine in the treatment of recurrent intracranial glioblastoma.
J Clin Oncol
; 28(7): 1168-74, 2010 Mar 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-20124186
9.
A phase I clinical trial with monoclonal antibody ch806 targeting transitional state and mutant epidermal growth factor receptors.
Proc Natl Acad Sci U S A
; 104(10): 4071-6, 2007 Mar 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-17360479